Sepracor Suits Over Planned Generic Xyzal Pile Up
A lawsuit accusing Barr Pharmaceuticals Inc. of infringement for its planned generic version of allergy drug Xyzal has become the fourth suit filed by drugmakers Sepracor Inc. and UCB SA over...To view the full article, register now.
Already a subscriber? Click here to view full article